Literature DB >> 23419864

Estradiol attenuates spinal cord injury-induced pain by suppressing microglial activation in thalamic VPL nuclei of rats.

Elham Saghaei1, Fatemeh Abbaszadeh, Kobra Naseri, Samar Ghorbanpoor, Mina Afhami, Ali Haeri, Farzaneh Rahimi, Masoumeh Jorjani.   

Abstract

In our previous study we showed that central pain syndrome (CPS) induced by electrolytic injury caused in the unilateral spinothalamic tract (STT) is a concomitant of glial alteration at the site of injury. Here, we investigated the activity of glial cells in thalamic ventral posterolateral nuclei (VPL) and their contribution to CPS. We also examined whether post-injury administration of a pharmacological dose of estradiol can attenuate CPS and associated molecular changes. Based on the results,in the ipsilateral VPL the microglial phenotype switched o hyperactive mode and Iba1 expression was increased significantly on days 21 and 28 post-injury. The same feature was observed in contralateral VPL on day 28 (P<.05). These changes were strongly correlated with the onset of CPS (r(2)=0.670). STT injury did not induce significant astroglial response in both ipsilateral and contralateral VPL. Estradiol attenuated bilateral mechanical hypersensitivity 14 days after STT lesion (P<.05). Estradiol also suppressed microglial activation in the VPL. Taken together, these findings indicate that selective STT lesion induces bilateral microglia activation in VPL which might contribute to mechanical hypersensitivity. Furthermore, a pharmacological dose of estradiol reduces central pain possibly via suppression of glial activity in VPL region.
Copyright © 2013 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23419864     DOI: 10.1016/j.neures.2013.01.010

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  9 in total

1.  Estradiol attenuates spinal cord injury-related central pain by decreasing glutamate levels in thalamic VPL nucleus in male rats.

Authors:  Asieh Naderi; Ali Reza Asgari; Reza Zahed; Ali Ghanbari; Razieh Samandari; Masoumeh Jorjani
Journal:  Metab Brain Dis       Date:  2014-05-31       Impact factor: 3.584

2.  Daily Fluctuations of Progesterone and Testosterone Are Associated With Fibromyalgia Pain Severity.

Authors:  Meredith Schertzinger; Kate Wesson-Sides; Luke Parkitny; Jarred Younger
Journal:  J Pain       Date:  2017-12-14       Impact factor: 5.820

3.  In vivo microdialysis of glutamate in ventroposterolateral nucleus of thalamus following electrolytic lesion of spinothalamic tract in rats.

Authors:  A Ghanbari; A R Asgari; G R Kaka; H R Falahatpishe; A Naderi; M Jorjani
Journal:  Exp Brain Res       Date:  2013-11-02       Impact factor: 1.972

Review 4.  Sex differences in pain along the neuraxis.

Authors:  Peyton Presto; Mariacristina Mazzitelli; Riley Junell; Zach Griffin; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2022-03-21       Impact factor: 5.273

Review 5.  Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Mona Bawazeer
Journal:  Front Cell Neurosci       Date:  2019-08-02       Impact factor: 5.505

Review 6.  Estrogen receptors in pain modulation: cellular signaling.

Authors:  Qing Chen; Wenxin Zhang; Neeti Sadana; Xinzhong Chen
Journal:  Biol Sex Differ       Date:  2021-02-10       Impact factor: 5.027

7.  Toll-like receptor 4/nuclear factor-kappa B pathway is involved in radicular pain by encouraging spinal microglia activation and inflammatory response in a rat model of lumbar disc herniation.

Authors:  Lirong Zhu; Yangliang Huang; Yuming Hu; Qian Tang; Yi Zhong
Journal:  Korean J Pain       Date:  2021-01-01

8.  HSP70 alleviates spinal cord injury by activating the NF-kB pathway.

Authors:  Bingqiang Xu; Jun Wang; Shizhang Liu; Huitong Liu; Xiaoxia Zhang; Jiyuan Shi; Le Ji; Jingyuan Li
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-12-01       Impact factor: 2.041

9.  In vitro and in vivo characterization of the new analgesic combination Beta-caryophyllene and docosahexaenoic Acid.

Authors:  Paolo Fiorenzani; Stefania Lamponi; Agnese Magnani; Ilaria Ceccarelli; Anna Maria Aloisi
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-07       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.